APA (7th ed.) Citation

Gamerith, G., Auer, T., Amann, A., Putzer, D., Schenk, B., Kircher, B., . . . Loeffler-Ragg, J. (2014). Increase in antibody-dependent cellular cytotoxicity (ADCC) in a patient with advanced colorectal carcinoma carrying a KRAS mutation under lenalidomide therapy. Cancer Biology & Therapy, 15(3), 266. https://doi.org/10.4161/cbt.27327

Chicago Style (17th ed.) Citation

Gamerith, Gabriele, Thomas Auer, Arno Amann, Daniel Putzer, Bettina Schenk, Brigitte Kircher, Wolfgang Hilbe, Heinz Zwierzina, and Judith Loeffler-Ragg. "Increase in Antibody-dependent Cellular Cytotoxicity (ADCC) in a Patient with Advanced Colorectal Carcinoma Carrying a KRAS Mutation Under Lenalidomide Therapy." Cancer Biology & Therapy 15, no. 3 (2014): 266. https://doi.org/10.4161/cbt.27327.

MLA (9th ed.) Citation

Gamerith, Gabriele, et al. "Increase in Antibody-dependent Cellular Cytotoxicity (ADCC) in a Patient with Advanced Colorectal Carcinoma Carrying a KRAS Mutation Under Lenalidomide Therapy." Cancer Biology & Therapy, vol. 15, no. 3, 2014, p. 266, https://doi.org/10.4161/cbt.27327.